Literature DB >> 24337347

Investigating commercial cellulase performances toward specific biomass recalcitrance factors using reference substrates.

Xiaohui Ju1, Mark Bowden, Mark Engelhard, Xiao Zhang.   

Abstract

Three commercial cellulase preparations, Novozymes Cellic(®) Ctec2, Dupont Accellerase(®) 1500, and DSM Cytolase CL, were evaluated for their hydrolytic activity using a set of reference biomass substrates with controlled substrate characteristics. It was found that lignin remains a significant recalcitrance factor to all the preparations, although different enzyme preparations respond to the inhibitory effect of lignin differently. Also, different types of biomass lignin can inhibit cellulase enzymes in different manners. Enhancing enzyme activity toward biomass fiber swelling is an area significantly contributing to potential improvement in cellulase performance. While the degree of polymerization of cellulose in the reference substrates did not present a major recalcitrance factor to Novozymes Cellic(®) Ctec2, cellulose crystallite has been shown to have a significant lower reactivity toward all enzyme mixtures. The presence of polysaccharide monooxygenases (PMOs) in Novozymes Ctec2 appears to enhance enzyme activity toward decrystallization of cellulose. This study demonstrated that reference substrates with controlled chemical and physical characteristics of structural features can be applied as an effective and practical strategy to identify cellulosic enzyme activities toward specific biomass recalcitrance factor(s) and provide specific targets for enzyme improvement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337347     DOI: 10.1007/s00253-013-5450-4

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  1 in total

1.  A comparative study of the enzymatic hydrolysis of batch organosolv-pretreated birch and spruce biomass.

Authors:  Vijayendran Raghavendran; Christos Nitsos; Leonidas Matsakas; Ulrika Rova; Paul Christakopoulos; Lisbeth Olsson
Journal:  AMB Express       Date:  2018-07-10       Impact factor: 3.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.